Advertisement

Topics

GSK to study consumer health buys but pharma top priority

10:22 EDT 25 Oct 2017 | Reuters

LONDON (Reuters) - GlaxoSmithKline will look at acquisition options to bulk up its consumer health business as rivals like Pfizer and Merck KGaA quit the field, but its top investment priority is bolstering prescription drugs.

Original Article: GSK to study consumer health buys but pharma top priority

NEXT ARTICLE

More From BioPortfolio on "GSK to study consumer health buys but pharma top priority"

Quick Search
Advertisement
 

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...